ADMA-44.72%20.0%
DYN+107.47%20.0%
INSM-4.63%20.0%
IONS+39.94%20.0%
NBIX+12.66%20.0%
As of Aug 24, 2026, 4:53 AM ET
Rare Diseases '25: RNA Therapy & Protein Mod Constituents
ADMA Biologics, Inc.ADMA | 20.0% | 0.82% | -0.66% | 18.98% | 16.31% | -46.05% | -36.80% | -51.36% | -46.52% | 662.79% | -44.72% | $2.28B |
Dyne Therapeutics, Inc.DYN | 20.0% | 0.46% | -2.28% | 6.79% | 3.65% | 33.44% | 67.09% | 163.37% | -43.91% | 57.61% | 107.47% | $4.87B |
Insmed IncorporatedINSM | 20.0% | 0.55% | -5.13% | 17.63% | 27.56% | -27.74% | -15.78% | 71.26% | 59.53% | 396.92% | -4.63% | $27.26B |
Ionis Pharmaceuticals, Inc.IONS | 20.0% | 1.69% | 7.80% | 5.64% | 15.40% | -24.48% | -26.38% | 108.08% | 27.32% | 53.06% | 39.94% | $9.93B |
Neurocrine Biosciences, Inc.NBIX | 20.0% | -0.24% | -5.79% | -13.20% | -8.53% | 7.57% | 15.36% | 40.86% | -0.16% | 63.82% | 12.66% | $15.34B |
| Theme return | — | 0.66% | -1.21% | 8.47% | 11.80% | -9.98% | 0.39% | 68.67% | 12.97% | 316.91% | 25.64% | — |
| Average | 20.0% | 0.66% | -1.21% | 7.17% | 10.88% | -11.45% | 0.70% | 66.44% | -0.75% | 246.84% | 22.14% | $11.94B |
| Median | 20.0% | 0.55% | -2.28% | 6.79% | 15.40% | -24.48% | -15.78% | 71.26% | -0.16% | 63.82% | 12.66% | $9.93B |
| Std Dev | 0.0% | 0.62% | 4.88% | 11.54% | 12.31% | 28.32% | 37.51% | 71.67% | 40.94% | 245.92% | 50.74% | $8.87B |
| Min | 20.0% | -0.24% | -5.79% | -13.20% | -8.53% | -46.05% | -36.80% | -51.36% | -46.52% | 53.06% | -44.72% | $2.28B |
| Max | 20.0% | 1.69% | 7.80% | 18.98% | 27.56% | 33.44% | 67.09% | 163.37% | 59.53% | 662.79% | 107.47% | $27.26B |
| % Positive Tickers | 80.00% | 20.00% | 80.00% | 80.00% | 40.00% | 40.00% | 80.00% | 40.00% | 100.00% | 60.00% |
Default: Wgt ↓ · Click headers to sort · Shift+click secondary
About this theme
Rare Diseases '25: RNA Therapy & Protein Mod tracks 5 publicly listed stocks in this theme: ADMA, DYN, INSM, IONS, NBIX. See the constituent table for details.